 REDWOOD CITY, Calif., Nov. 01, 2022 GLOBE NEWSWIRE -- Rezolute, Inc. Nasdaq: RZLT, a clinical-stage biopharmaceutical company dedicated to developing transformative therapies with the potential to shift the treatment paradigms of devastating metabolic diseases, today announced that Nevan Charles Elam, Chief Executive Officer and Founder, will participate in a fireside chat at the Jefferies London Healthcare Conference on Thursday, November 17, 2022, at 11:25 a.m. EST4:25 p.m. GMT. 